FDA Should Broaden Use Of Real-World Data, Report Says
The U.S. Food and Drug Administration should clear up how real-world evidence can be used in clinical trials and post-market surveillance for drugs and medical devices and consider expanded uses of...To view the full article, register now.
Already a subscriber? Click here to view full article